# LABETALOL HYDROCHLORIDE
> **ANDA207863** · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2019-02-04
## Drug
- **FDA Application Number:** ANDA207863
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LABETALOL HYDROCHLORIDE
- **Generic name:** Labetalol Hydrochloride
- **Active ingredients:** LABETALOL HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HIBROW HLTHCARE
- **First approval:** 2019-02-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207863)
---
*AI Analytics · CC0 1.0*